Results 211 to 220 of about 237,925 (267)

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou   +7 more
wiley   +1 more source

Development of a gut microbiota model for the analysis of bacterial modifications of xenobiotics. [PDF]

open access: yesAppl Microbiol Biotechnol
Hager N   +7 more
europepmc   +1 more source

Unraveling the gut microbiota-brain axis: Mechanisms, pathophysiology, and therapeutic opportunities. [PDF]

open access: yesiScience
Jiang C   +13 more
europepmc   +1 more source

Children's gut microbiota predicts the efficacy of obesity treatment. [PDF]

open access: yesGut Microbes
Alcázar M   +8 more
europepmc   +1 more source

Gut microbiota and sepsis-associated acute kidney injury: a narrative review. [PDF]

open access: yesFront Immunol
Zhang H   +10 more
europepmc   +1 more source

Osteoporosis and gut microbiota: current understandings. [PDF]

open access: yesFront Immunol
Liu Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy